---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-005030"
form_type: "8-K"
ticker: "ROIV"
cik: "0001635088"
company_name: "Roivant Sciences Ltd."
filed_at: "2023-02-07T23:59:59+00:00"
generated_at: "2026-06-19T22:57:02.547164+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Roivant Sciences prices upsized public offering of 30.7M common shares at $7.50, raising ~$230M gross

## Summary
- Offering of 30,666,665 shares priced at $7.50 per share; gross proceeds ~$230M before expenses.
- Upsized from initial 26,666,666 shares; underwriters' 30-day option exercised in full.
- Bookrunners: Goldman Sachs, SVB Securities, Cowen, Cantor Fitzgerald.
- Shares sold by Roivant; offering closed February 7, 2023.

## SEC filing metadata
- accession: 0001140361-23-005030
- form_type: 8-K
- ticker: ROIV
- cik: 0001635088
- company_name: Roivant Sciences Ltd.
- filed_at: 2023-02-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635088/000114036123005030/0001140361-23-005030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635088/000114036123005030/ny20006513x5_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-005030
- JSON: https://secwatch.observer/filing/0001140361-23-005030.json
- Plain text: https://secwatch.observer/filing/0001140361-23-005030.txt

## Key facts
- Material Agreements
  Roivant Sciences Ltd. entered into Underwriting Agreement with Goldman Sachs & Co. LLC, SVB Securities LLC, Cowen and Company, LLC and Cantor Fitzgerald & Co. valued at approximately $230 million (effective 2023-02-02).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Goldman Sachs & Co. LLC, SVB Securities LLC, Cowen and Company, LLC and Cantor Fitzgerald & Co.
  - Value: approximately $230 million
  - Effective: 2023-02-02
  source text: On February 2, 2023, Roivant Sciences Ltd. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, SVB Securities LLC, Cowen and Company, LLC and Cantor Fitzgerald & Co. (the “Representatives”), as the representatives of the underwriters named therein, relating to the issuance and sale in an underwritten offering (the “Offering”) of 30,666,665 of the Company’s common shares
  evidence_url: https://www.sec.gov/Archives/edgar/data/1635088/000114036123005030/0001140361-23-005030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.